Noopept

A synthetic peptide-derived nootropic often grouped with racetams due to similar effects, though it is technically a dipeptide analog of piracetam. Roughly 1000x more potent by weight than piracetam, requiring only 10-30 mg per dose. It provides both immediate cognitive enhancement and long-term neuroprotective benefits through BDNF and NGF upregulation.

Dosage

Standard: 10-30 mg sublingually or orally, 2-3 times daily. Sublingual administration provides faster onset. Do not exceed 30 mg per dose.

Dosages shown are for research reference only. Always consult a qualified healthcare provider.

Half-Life

30-60 minutes (active metabolite cycloprolylglycine persists longer)

Administration

Oral or sublingual (sublingual preferred for faster onset and higher bioavailability). Available as powder, capsules, or sublingual tablets.

Shop Noopept

99%+ purity · third-party lab tested

Browse →

Mechanism of Action

Noopept modulates AMPA and NMDA receptors similarly to racetams through positive allosteric modulation. Its key distinguishing feature is upregulation of BDNF (brain-derived neurotrophic factor) and NGF (nerve growth factor) via activation of TrkB and TrkA receptor signaling cascades — these neurotrophins are essential for neuronal growth, survival, dendritic arborization, and synaptic plasticity. Noopept inhibits glutamate-induced excitotoxicity by reducing calcium influx through NMDA receptors and modulating the NR2B subunit. It activates the PI3K/Akt and MAPK/ERK pathways downstream of neurotrophin receptors. The active metabolite cycloprolylglycine (a cyclic dipeptide) has endogenous nootropic activity, potentially acting as a trace amine-associated receptor ligand. Neuroprotection is further mediated through antioxidant effects and mitochondrial stabilization.

Regulatory Status

Prescription medication in Russia. Available as a research compound or supplement in most other countries.

Risks & Safety

Common

Headache (especially without choline supplementation), irritability at higher doses, brain fog in some users.

Serious

No serious adverse effects documented.

Rare

Emotional blunting at high doses, insomnia, allergic reactions.

Compare Noopept With

Research Papers

10
Cognitive Enhancer Noopept Activates Transcription Factor HIF-1.

Published: September 19, 2020

AI Summary

Noopept was shown to increase both the basal DNA-binding activity of HIF-1 and the activity induced by various hypoxia mimetics. It was revealed that the effect of noopept is accompanied by changes in gene expression, which belong to different metabolic pathways and are controlled by the transcription factor HIF-1.

Effects of noopept on ocular, pancreatic and renal histopathology in streptozotocin induced prepubertal diabetic rats.

Published: November 21, 2023

AI Summary

Renal tubule diameter and corneal and retinal thickness were increased significantly in DC groups compared to the control group. Our findings suggest that noopept is protective against DM end organ complications in streptozotocin induced diabetic pubertal rats.

Effects of noopept on cognitive functions and pubertal process in rats with diabetes.

Published: September 14, 2019

AI Summary

Of this reason new approaches in treatment are needed. Noopept researches suggest it to have anti-diabetic properties.

[The original novel nootropic and neuroprotective agent noopept].

Published: February 24, 2002

AI Summary

Experimental investigations of noopept (N-phenylacetyl-L-polyglycine ethyl ester) showed that the new drug exceeds pyracetam both with respect to the effective dose level (1000 times lower for noopept than for pyracetam) and in the spectrum of mnemotropic activity.

Neuroprotective Dipeptide Noopept Prevents DNA Damage in Mice with Modeled Prediabetes.

Published: December 26, 2019

AI Summary

Despite moderate hyperglycemia and increased malondialdehyde level, the intensity of DNA damage in cells of the pancreas, liver, and kidneys significantly surpassed the control values. They indicate the possibility of pharmacological protection of pancreatic β cells with the neuroprotective drug and provide an important argument in favor o...

Immunopharmacological properties of noopept.

Published: July 7, 2007

AI Summary

Noopept, a peptide analog of piracetam, enhanced phagocytic activity of mouse peritoneal macrophages, stimulated humoral and cellular immune response to various antigens, and markedly increased spontaneous proliferative activity of splenocytes. In animals with secondary immune deficiency caused by c

Drug with Neuroprotective Properties Noopept Does Not Stimulate Cell Proliferation.

Published: February 19, 2019

AI Summary

The possible mitogenic action of Noopept was estimated by its effect on cell proliferation. These data suggest that Noopept does not stimulate cell growth.

Noopept; a nootropic dipeptide, modulates persistent inflammation by effecting spinal microglia dependent Brain Derived Neurotropic Factor (BDNF) and pro-BDNF expression throughout apoptotic process.

Published: February 11, 2021

AI Summary

Our findings revealed hyperalgesia and spinal cell apoptosis significantly increased during the acute phase of CFA-induced inflammation but was then followed by a decrement in the chronic phase of the study.

Noopept Attenuates Diabetes-Mediated Neuropathic Pain and Oxidative Hippocampal Neurotoxicity via Inhibition of TRPV1 Channel in Rats.

Published: October 8, 2021

AI Summary

Noopept (NP) acted several protective antioxidant actions against oxidative neurotoxicity. In conclusion, the treatment of NP induced protective effects against STZ-induced adverse peripheral pain and HIPPO oxidative neurotoxicity.

Effect of nootropic dipeptide noopept on CA1 pyramidal neurons involves α7AChRs on interneurons in hippocampal slices from rat.

Published: October 31, 2022

AI Summary

We have previously shown that NP significantly increased the frequency of spontaneous IPSCs in hippocampal CA1 pyramidal cells mediated by the activation of inhibitory interneurons in stratum radiatum. These results imply the involvement of α7 nAChRs in the modulation of hippocampal neuronal activity caused by NP and indicate that a7 nAChR...

Frequently Asked Questions

What is Noopept used for?

A synthetic peptide-derived nootropic often grouped with racetams due to similar effects, though it is technically a dipeptide analog of piracetam. Roughly 1000x more potent by weight than piracetam, requiring only 10-30 mg per dose. It provides both immediate cognitive enhancement and long-term neuroprotective benefits through BDNF and NGF upregulation.

What are the side effects of Noopept?

Common: Headache (especially without choline supplementation), irritability at higher doses, brain fog in some users. Serious: No serious adverse effects documented. Rare: Emotional blunting at high doses, insomnia, allergic reactions.

How is Noopept administered?

Noopept is administered via oral or sublingual (sublingual preferred for faster onset and higher bioavailability). available as powder, capsules, or sublingual tablets..

What is the half-life of Noopept?

The half-life of Noopept is 30-60 minutes (active metabolite cycloprolylglycine persists longer).

Related Nootropics

Agmatine Sulfate

A metabolite of L-arginine produced by decarboxylation. Agmatine is an endogenous neuromodulator that acts on multiple receptor systems — it blocks NMDA receptors, activates imidazoline receptors, inhibits nitric oxide synthase, and modulates opioid signaling. This makes it useful for neuropathic pain, mood, stress resilience, and as a complement to other nootropics. Also enhances insulin sensitivity and nitric oxide production.

Mood & AnxietyNeuroprotection

ALCAR

Acetyl-L-Carnitine is an acetylated form of L-Carnitine that crosses the blood-brain barrier more effectively than regular L-Carnitine. In the brain, it donates its acetyl group for acetylcholine synthesis and supports mitochondrial fatty acid oxidation for energy. Used clinically for age-related cognitive decline, depression, and diabetic neuropathy.

MitochondrialMood & AnxietyNeuroprotection

Aniracetam

A fat-soluble racetam roughly 5-10x more potent than Piracetam by weight. Known for its anxiolytic (anti-anxiety) properties alongside cognitive enhancement — a combination that makes it popular for social situations and creative work. It modulates both glutamate and dopamine/serotonin systems, giving it a unique mood-lifting quality that other racetams lack.

RacetamsMood & Anxiety

B-Complex

The B vitamins (B1, B2, B3, B5, B6, B9, B12) are essential coenzymes in brain energy metabolism, neurotransmitter synthesis, and methylation reactions. Deficiency in any B vitamin impairs cognitive function. B12 and folate deficiency specifically cause irreversible neurological damage if untreated. A high-quality B-complex is foundational for any nootropic regimen, particularly for vegetarians, older adults, and those under chronic stress.

NeuroprotectionMood & Anxiety

Bacopa Monnieri

An Ayurvedic herb used for thousands of years as a memory enhancer. Modern research confirms it — Bacopa reliably improves memory formation, recall speed, and information retention. The catch is that benefits require 8-12 weeks of daily use to manifest; it is not an acute cognitive enhancer. The bacosides (active compounds) are also mildly sedating, making evening dosing common.

AdaptogensNeuroprotection

Black Seed Oil

Extracted from Nigella sativa seeds, black seed oil contains thymoquinone — a compound with potent anti-inflammatory, antioxidant, and neuroprotective properties. Used in traditional Middle Eastern medicine for over 2,000 years, modern research supports cognitive benefits through anti-neuroinflammation, acetylcholinesterase inhibition, and GABA modulation. Also supports metabolic health and immune function.

NeuroprotectionMood & AnxietyAdaptogens